Introduction
============

Regional anaesthesia, particularly spinal anaesthesia is a popular anaesthetic technique because of its simplicity, efficacy and safety. Edomwonyi et al reported that neuraxial block for prostatectomy gained overwhelming popularity in their institution[@R1]. However one of the problems of single shot spinal anaesthesia remains the limited duration of anaesthesia, even with the use of bupivacaine which is a long acting local anaesthetic agent. Various methods have been used to prolong the duration of action of local anaesthetics when used for sub-arachnoid block.

Such methods include the addition of drugs like ketamine, magnesium sulphate, neostigmine, clonidine and opioids to local anaesthetic agents[@R2].

Alpha-adrenergic mechanism of analgesia has been exploited for more than 100years[@R3]. Alpha[@R2] adrenergic agonists are routinely used in the treatment of hypertension as they reduce central sympathetic outflow and modulate pre-synaptic transmitter release[@R3]. They also have hypnotic effects[@R4]. Alpha^2^-adenoceptors are located on primary afferent terminals (both at the peripheral and spinal endings). Neurons in the superficial laminae of the spinal cord and within several brainstem nuclei have been implicated in analgesia[@R4].

Clonidine, an α^2^ adrenergic agonist produces analgesia in humans at spinal and supra-spinal sites of action[@R5],[@R6]. The drug has been demonstrated to inhibit neurotransmission of both A delta and C nervefibers which mediate pin-prick, surgical pain, and tourniquet pain[@R7],[@R8]. Gaumann et al have shown that clonidine enhances the effect of lidocaine on C-fibers action potential[@R9].

Clonidine can be administered systemically, epidurally and intrathecally. Oral administration of clonidine results in virtually complete absorption and peak plasma concentration occurs 1--3 hours after administration[@R5]. The drug is highly lipid soluble easily crosses the blood-brain barrier and therefore may interact with α-adrenergic receptors at spinal and supraspinal sites within the central nervous system[@R10]. Several studies have been done to evaluate the effects of oral clonidine when used as a pre-medicant before administering spinal anaesthesia[@R3],[@R11],[@R12],[@R13],[@R14].

The aim of this study was to evaluate if a dose-related effect exists when two different doses of oral clonidine are administered as a pre-medicant in the enhancement of bupivacaine spinal anaesthesia, to compare the haemodynamic effects of such doses and to evaluate the sedative effect of oral clonidine.

Material and methods
====================

The prospective randomized, double blind controlled study was approved by institution ethical review committee and consisted of 108 consenting ASA I and II patients who were randomized into three groups. Patients with bleeding disorders, neurological disorders, previous history of adverse reaction to bupivacaine and clonidine, and, patients on anti-hypertensive therapy were excluded from the study. After detailed examination , the patients between ages 18 and 65 years undergoing lower abdominal or lower limbs surgeries under spinal anaesthesia were assigned into three groups.

The control group A (n=36) had no clonidine pre-medication while groups B (n=36) and C (n=36) received 100 µg and 200 µg of oral clonidine one hour before spinal anaesthesia respectively.

Using a multiparameter patient monitor, the heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP) and arterial oxygen saturation were measured non-invasively. The parameters were recorded before pre-medication with oral clonidine, at the time spinal anaesthesia was given (zero minute) and at 30 min after anaesthesia.

Sedation score was assessed using a four point scale (1=Awake, 2=Drowsy but responsive to verbal stimulus, 3=Drowsy but arousable to touch, 4=unarousable)[@R5]. An intravenous line was secured using a 16-gauge cannula and each patient was pre-loaded with 15ml/kg of normal saline over 20 minutes. Patients were then placed in the sitting position. Using aseptic technique, skin infiltration was done using 1% lidocaine and lumbar puncture was performed using a 25G Whitacre spinal needle at L2/L3 or L3/L4 intervertebral space. Once free flow of cerebrospinal fluid was obtained, 15mg of 0.5% heavy bupivacaine (Myungmoon Pharm. Co, LTD), was injected. Haemodynamic parameters were monitored every 2 min initially for the first ten minutes, then every 5 min until end of surgery. Hypotension was defined as reduction in systolic blood pressure by 25% below pre-anaesthetic value or decreased systolic pressure below 90mmHg and was noted if it occurred and treated with rapid infusion of normal saline, oxygen administration, and ephedrine in 3mg bolus doses titrated to effect. Heart rates less than 50 beats per min were treated with titrated doses of atropine 0.6mg as required.

The level of sensory anaesthesia was assessed in the midclavicular line bilaterally using loss of sensation to pinprick with a 21G needle. Response to pinprick was studied every 5minutes for 30 minutes after the injection of the local anaesthetic. Onset of anaesthesia was considered as appearance of sensory block at L1. The degree of motor block was assessed at 2 minutes and then at 5 minutes interval for 20 minutes, using a modified Bromage scale ( 0 = no motor block, 1=inability to raise the extended legs, 2= inability to flex the knees, 3= inability to flex the ankle joints). Assessment was not carried out during surgery but was continued after surgery, every 30 minutes until full recovery. The duration of analgesia was considered as time between onset and time when sensory level weaned off to L1.

Post-operatively in the recovery room the total duration of sensory and motor block was noted.

Haemodynamicaly stable patients with sensory level lower than L1 and ability to lift both lower limbs were discharged to the ward.

Data analysis
=============

The data generated were presented as means and standard deviations, proportions and percentages as appropriate. Statistical analyses were done using computer software package Excel 2007 version. Means were compared using Student\'s t-test for 2 groups or ANOVA for 3 groups. Categorical data were compared with Chi-square test. P value ≤ 0.05 was considered statistically significant.

Results
=======

All the patients in the three groups had comparable demographic characteristics ([Table 1](#T1){ref-type="table"}).

###### 

Demographic characteristics of surgical patients given oral clonidine

            N    Male: female   Age (year)    WT (Kg)       Ht(m)       ASA I/II
  --------- ---- -------------- ------------- ------------- ----------- ----------
  Group A   36   10:26          40.27±14.51   71.27±17.63   1.64±0.09   23/13
  Group B   36   20:16          41.75±10.89   77.83±20.43   1.53±0.18   26/10
  Group C   36   22:14          40.52±13.05   63.61±8.9     1.62±0.09   14/22
  P value                       **1.161**     **0.900**     **0.900**   

Values are mean±SD

No significant differences among groups

[Table II](#T2){ref-type="table"} show the haemodynamic variables at rest, before oral clonidine was administered, at zero minute, that is, before spinal anaesthesia was given and at thirty minutes after spinal anaesthesia. There were no significant differences in the variables between the three groups at rest before oral clonidine was given. The mean HR at zero minute was lower in the clonidine groups than the control group but this was only statistically significant when the control group was compared with the 200µg clonidine group (p=0.05).

###### 

Heamodynamic parameters of patients at rest (baseline), zero minute before instituting spinal and 30 minutes after spinal anaesthesia

                  At rest      Before spinal   30 min
  ----- --------- ------------ --------------- ------------
  HR    A         82.5±15.6    97.5±22.7       92±19.8
        B         87.1±88      96.6±8.8        83.9±19.9
        C         91.9±19.8    87.0±12         84.6±13.7
        P value   1.801        0.164           0.044
  SBP   A         135±6.7      136.7±17.7      126.4±17.2
        B         139.1±17.1   148.3±22.2      130.1±11.6
        C         121.5±11.6   120.3±10        106.8±8.8
        P value   0.258        0.584           0.065
  DBP   A         76.8±14.5    76.8±14.5       70.5±148
        B         81±11        81±11           72.1±12
        C         70.6±8.3     70.6±8.3        62.3±8.7
        P value   0.760        0.760           0.352
  MAP   A         98.4±13.5    98.8±14.4       92.3±15.1
        B         106.3±31.4   105.3±14.8      93.4±10.7
        C         90.7±7.6     89.6±9.6        78.7±8
        P value   1.012        0.717           0.112

N = 36 patients in each group

GROUP A = No clonidine

GROUP B = 100µg

GROUP C = 200 µg

The table also shows haemodynamic measurements thirty minutes after spinal anaesthesia. The mean HR in group B (100µg) and group C (200 µg) were significantly lower than the control group, p= 0.05 and p=0.024 respectively ([Table III](#T3){ref-type="table"}). There was no difference in the mean HR between the clonidine groups p= 0.307([Table III](#T3){ref-type="table"}).

###### 

Comparing P values of haemodynamic parameters of groups at rest, before spinal (zero minutes) and 30 minutes

                 P value at rest   P value before spinal   P value 30 min
  ----- -------- ----------------- ----------------------- ----------------
  HR    A vs B   0.077             0.809                   0.005
        B vs C   0.001             0.000                   0.307
        A vs C   0.000             0.005                   0.024
                                                           
  SBP   A vs B   0.146             0.000                   0.196
        B vs C   0.000             0.000                   0.000
        A vs C   0.000             0.000                   0.000
                                                           
  DBP   A vs B   0.000             0.000                   0.513
        B vs C   0.158             0.000                   0.000
        A vs C   0.259             0.009                   0.001
                                                           
  MAP   A vs B   0.000             0.006                   0.667
        B vs C   0.002             0.000                   0.000
        A vs C   0.000             0.000                   0.000

The mean SBP, DBP and MAP of the patients in group C (200µg) group were significantly lower than those of the control group p= 0.000, 0.001 and 0.000 respectively ([Table III](#T3){ref-type="table"}). The SBP, DBP and MAP of the 200µg clonidine were also significantly lower than those of the group B (100µg) p= 0.000 for each variable ([Table III](#T3){ref-type="table"}).

[Table IV](#T4){ref-type="table"} shows the absolute degree of change of the haemodynamic parameters of all the groups from the baseline. In the control group A the mean HR significantly increased from the baseline (p = 0.01), the mean SBP was significantly reduced from the baseline (p= 0.028) while the change in the parameters of mean DBP and MAP from the baseline were not statistically significant (p = 1.101 and 0.103 respectively).

###### 

Haemodynamic changes of the groups from baseline to 30 minutes after spinal anaesthesia

            Baseline     30 min       \% change   P value
  --- ----- ------------ ------------ ----------- ---------
  A   HR    82.5±8.8     92±19.7      11.48       0.010
      SBP   135.1±16.7   126.4±17.2   6.40        0.028
      DBP   75.9±10.3    70.5±14.8    7.03        1.101
      MAP   98.4±13.5    92.3±15.1    6.13        0.103
                                                  
  B   HR    87.1±8.8     83.9±13.7    4.95        0.000
      SBP   139.1±17.1   130.1±11.6   6.47        0.000
      DBP   76.1±9.6     72.1±12      5.36        0.003
      MAP   106.3±31.4   93.4±10.7    12.10       0.017
                                                  
  C   HR    91.9±19.8    84.6±13.7    7.97        0.133
      SBP   121.5±11.6   106.8±8.8    12.02       0.000
      DBP   73.9±8       62.3±8.7     15.07       0.000
      MAP   90.7±7.6     78.7±8       13.22       0.000

The absolute degree of haemodynamic changes of group B (100µg of oral clonidine) from the baseline showed significant reductions in the mean HR (p= 0.000), SBP (p= 0.000), DBP ( p= 0.003) and MAP (p= 0.017).

The 200 µg oral clonidine group (group C) showed significant reductions in SBP, DBP and MAP at 30 minutes (p= 0.000 respectively) as shown in [Table IV](#T4){ref-type="table"}. However there was no statistically significant reduction in mean HR (p=0.133)

Onset of Sensory Block ([Table V](#T5){ref-type="table"})
---------------------------------------------------------

###### 

Comparison of Onset of Sensory and Motor Block amongst the Groups (Mean ± SD)

  Groups                  Sensory Block (mins)   Motor Block (mins)
  ----------------------- ---------------------- --------------------
  Group A                 6.69 ±2.55             2.05 ± 0.41
  Group B                 2.19 ± 0.7             1.02 ± 0.16
  Group C                 2.08 ± 0.28            1.0 ± 0.0
                                                 
  Sensory block p value   Motor block p value    
  GROUP A vs B            0.000                  0.000
  GROUP A vs C            0.000                  0.000
  GROUP B vs C            0.348                  0.317

The onset of sensory block was significantly faster in the clonidine groups than the control group, It was 6.69 ±2.55 mins in the control group compared to 2.19 ±0.7 mins in the 100µg clonidine group (p= 0.000) and 2.08 ±0.28mins in the 200 µg group (p= 0.000). There was no significant difference in onset of sensory block between the clonidine groups (p= 0.348)

Onset of Motor Block ([Table V](#T6){ref-type="table"})
-------------------------------------------------------

The onset of motor block was significantly faster in the clonidine groups than the control group.

It was 2.05 ±0.41mins in the control group compared to 1.02 ±0.16 mins in the 100 µg clonidine group (p= 0.000) and 1.00 ±0.00 mins in the 200 µg group (p= 0.0000). There was no significant difference in onset of motor block between the clonidine groups (p= 0.317).

Duration of Sensory Block ([Table VI](#T4){ref-type="table"})
-------------------------------------------------------------

###### 

Comparison of Duration of Sensory and Motor Block amongst the groups (Mean ± SD)

  GROUPS                  Sensory Block(Mins)   Motor Block (Mins)
  ----------------------- --------------------- --------------------
  Group A                 115.89 + 25.66        117.92+25.13
  Group B                 188.19 + 35.19        189.94+26.93
  Group C                 194.28 + 24.58        191.89+28.13
                                                
  Sensory block p value   Motor block p value   
  GROUP A vs B            0.000                 0.000
  GROUP A vs C            0.000                 0.000
  GROUP B vs C            0.138                 0.678

The duration of sensory block was significantly longer in the clonidine groups than the control group. It was 115.89 ±26.66mins in the control group compared to 188.19 ±35.19mins in the 100µg clonidine group (p= 0.000) and 194 ±24.58mins in the 200 µg group (p= 0.000). There was no significant difference in duration of sensory block between the two clonidine groups (p=0.138).

Duration of Motor Block ([Table VI](#T4){ref-type="table"})
-----------------------------------------------------------

The duration of motor block was also significantly longer in the clonidine groups than the control group. It was 117.92 ± 25.13 mins in the control group compared to 189.94 ±26.93 mins in the 100 µg clonidine group (p= 0.000) and 191.89 ±28.13 mins in the 200 µg clonidine group (p= 0.000). There was no difference in duration of motorblock between the two clonidine groups (p= 0.678).

Sedation Score
--------------

Sedation score showed that the patients in the clonidine groups were more sedated than those in the control group. All the patients (100%) in the control group were awake, while in the 100µg clonidine group 28.57% were awake and 71.43% were drowsy but responded to verbal stimulation. In the 200µg clonidine group, all the patients i.e. 100% were drowsy but responded to verbal stimulus ([Table VII](#T7){ref-type="table"}).

###### 

Degree of Sedation among the Groups

  GROUP     1 (%)   2(%)    3(%)   4(%)
  --------- ------- ------- ------ ------
  GROUP A   100     0       0      0
  GROUP B   28.57   71.43   0      0
  GROUP C   0       100     0      0

1: Awake

2: Drowsy but responsive to verbal stimulus

3: Drowsy but arousable to touch

4: Unarousable

Discussion
==========

The study showed that patients pre-medicated with 100µg clonidine had a 4.95% fall in heart rate at thirty minutes when compared to the base line, which was statistically significant(p=0.000). Group C (200µg) also had a 7.95% fall in heart rate at thirty minutes when compared to the baseline (p=0.133), while the control group had an increase in heart rate of 11.48% from the baseline when compared to thirty minutes which was statistically significant (p=0.010). The increase in heart rate in the control group was probably due to the lack of the net effects of clonidine which is to down-regulate, or at least reduce the sympathetic response. The result of the heart rate at zero minute and thirty minutes in group B (100µg) was similar to studies conducted by Swati et al[@R15]. Liu et al also reported a significant fall in heart rate in patients pre-medicated with 200µg of oral clonidine[@R5]. All the groups had a statistically significant fall in systolic blood pressure from the baseline, group A (6.40%), group B (6.47%) and group C(12.02%) probably due to the additive effects of spinal anaesthesia. These findings were similar to the study by Liu et al[@R2]. Group B (100µg) and group C (200µg) of oral clonidine had significant decrease in DBP and MAP, from the baseline (p\<0.05). This decrease was not seen in the control group A (p\>0.05).

Various studies have shown that oral clonidine, when used as pre-medication before spinal anaesthesia has effects on the duration of sensory and motor block[@R3],[@R5],[@R15],[@R16]. In the study by Swati et al[@R15] the duration was prolonged by 30--40 minutes. In all the previous studies mentioned above, a single dose of clonidine was used but in our study two different doses of clonidine were used and the aim was to establish if there was a dose related effect on the onset and duration of sensory and motor block.

The onset of sensory block at L1 was faster in the clonidine groups when compared with the control group. ([Table V](#T5){ref-type="table"}). This was comparable with the study of Aftab et al[@R3] .However, when the clonidine groups were compared, the difference in time of onset at L1 was not statistically significant p\>0.05. Similarly the onset of motor block was faster in the clonidine groups than the control group ([Table V](#T5){ref-type="table"}). This result was different from that of Afteb et al who reported that the onset of motor block was similar between the control group and patients pre-medicated with 150µg of oral clonidine[@R3].

Liu et al[@R5] and Harbhej et al[@R17] also found that 200µg of oral clonidine prolonged the duration of lignocaine and tetracaine spinal anaesthesia respectively. The study of Otalet al[@R12] compared the dose-related effects using three different doses of oral clonidine 75µg, 150µg and 300µg on tetracaine spinal anaesthesia. The dose response data suggested that the prolongation of sensory block by oral clonidine seems to plateau at a dose of 150µg because regression to L1 dermatome was increased by 45% with 75µg, 92% with 150µg and 76% with 300µg of oral clonidine respectively. In this study, the result of the comparison of the sensory and motor blocks of the control group to the clonidine groups is similar to other studies mentioned above[@R5],[@R12],[@R17]. The result shows a statistical significant increase in duration of sensory and motor blocks in the clonidine groups when compared to the control group (p\<0.05). Interestingly, there were no differences in the duration of sensory and motor blocks between the two clonidine groups in this study. Comparing these results with those of Ota et al[@R12], who concluded that the effect of oral clonidine on duration of tetracaine spinal anaesthesia seems to plateau at 150µg, this study shows that the effect of oral clonidine on duration of sensory and motor block in bupivacaine spinal anaesthesia is in the dose range of 100--200µg. This is because these dosages prolonged sensory and motor blocks almost equally. The mechanisms of how oral clonidine affects sensory and motor block remains unclear, however direct inhibition of A alpha motor fibers, C nerve fibers[@R8] and augmentation of intrathecal local anaesthetic effects[@R19] has been postulated to play a role in the effects of oral clonidine. Butterworth and Strichartz[@R8] demonstrated that analgesia after neuraxial administration of α~2~-adrenergic agonists may, in fact, result from direct inhibition of impulse conduction in the Aα and C fibers. However unlike the traditional local anaesthetics, clonidine produces greater inhibition of C fibers than Aα fibers[@R20]. Some of the analgesic efficacy of α~2~-adrenergic agonists following regional injection may result from a local anaesthetic -type of action on Aα and, especially, C fibers. In this study the duration of analgesia in the control group was 115.89±26.66 min while that of the clonidine groups were 188.14±35.19 min (100 µg) and 194±24.58 min (200 µg) respectively which was statistically significant p=0.00 this was similar to that of several studies[@R3],[@R14],[@R15]. The potent analgesic property of clonidine is because it acts at spinal and supraspinal sites, it has a non-opioid mechanism of analgesic action on the medullospinal noradrenergic pathway modulating spinal nociceptive processing and the α~2~-adrenergic receptor that are strategically located on the dorsal horn neurons of the spinal cord where it can either inhibit the release of nociceptive neurotransmitters such as substance 'P' or calcitonin gene related peptide.[@R14] Another analgesic mechanism is by the synergistic interaction between α~2~-adrenergic agonist and opiates in the spinal cord.[@R14]

Sedation has been shown to increase patient\'s satisfaction during regional anaesthesia[@R21] and may be considered as a means to increase the patient\'s acceptance of regional anaesthetic techniques.

For surgery under regional anaesthesia, sedation is a valuable tool to make it more convenient for the patient, the anaesthetist, and the surgeon. In this study, the incidence of sedation with 100µg of oral clonidine was 71.43% while the control group had zero percent. This is comparable to the pattern observed in the study by Swati et al in which the incidence of sedation using 100mcg of oral clonidine was 64% while the control group had zero percent[@R15]. However the incidence of sedation in the 200µg of oral clonidine was 100%, suggesting that the incidence of sedation had a dose response effect. Liu et al also reported that the incidence of sedation was greater in the group premedicated 200µg of oral clonidine and was in agreement with previous dose-response studies of oral clonidine[@R22],[@R23]. Clonidine produces a dose-dependent sedation over the dose range of 50--900µg of rapid onset (20minute) regardless of the route of administration[@R4].

Conclusion
==========

The study demonstrated that pre-medication of healthy patients with oral clonidine one hour prior to bupivacaine spinal anaesthesia gave a faster onset andlonger duration of spinal anaesthesia. Furthermore, it also provided a distinct advantage because of its sedative property.

Recommendations
===============

Based on the findings in this study, it is recommended that the use of oral clonidine pre-medication before bupivacaine spinal anaesthesia in adults is desirable.

Opioids which are one of the commonest agents added to local anaesthetic to prolong its duration is not always available in tertiary health centres and hardly available in non-specialist hospitals. Therefore, we advocate the use of oral clonidine as a pre-anaesthetic medication in all healthy adult surgical patients for elective surgical procedure involving the lower abdominal and lower limbs under bupivacaine spinal anaesthesia because it prolongs spinal anaesthesia, provides desirable sedative effects and a tolerable peri-operative heamodynamic profiles.
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